Abvc biopharma to present at the maxim group 2022 virtual growth conference

Fremont, ca, march 23, 2022 (globe newswire) -- via  newmediawire -- abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced that the company will be participating at the maxim group 2022 virtual growth conference, taking place march 28-30, 2022.
ABVC Ratings Summary
ABVC Quant Ranking